130 related articles for article (PubMed ID: 10925068)
1. Suicidal insulin overdose in a type 1 diabetic patient: relation of serum insulin concentrations to the duration of hypoglycemia.
Shibutani Y; Ogawa C
J Diabetes Complications; 2000; 14(1):60-2. PubMed ID: 10925068
[TBL] [Abstract][Full Text] [Related]
2. Estimated glucose requirement following massive insulin overdose in a patient with type 1 diabetes.
Fasching P; Roden M; Stühlinger HG; Kurzemann S; Zeiner A; Waldhäusl W; Laggner AN
Diabet Med; 1994 Apr; 11(3):323-5. PubMed ID: 8033534
[TBL] [Abstract][Full Text] [Related]
3. Massive insulin overdose: detailed studies of free insulin levels and glucose requirements.
Samuels MH; Eckel RH
J Toxicol Clin Toxicol; 1989; 27(3):157-68. PubMed ID: 2810441
[TBL] [Abstract][Full Text] [Related]
4. Duration of hypoglycemia and need for intravenous glucose following intentional overdoses of insulin.
Stapczynski JS; Haskell RJ
Ann Emerg Med; 1984 Jul; 13(7):505-11. PubMed ID: 6377986
[TBL] [Abstract][Full Text] [Related]
5. Intentional massive insulin overdose: recognition and management.
Roberge RJ; Martin TG; Delbridge TR
Ann Emerg Med; 1993 Feb; 22(2):228-34. PubMed ID: 8427437
[TBL] [Abstract][Full Text] [Related]
6. Poisoning with insulin glargine.
Brvar M; Mozina M; Bunc M
Clin Toxicol (Phila); 2005; 43(3):219-20. PubMed ID: 15902802
[No Abstract] [Full Text] [Related]
7. Octreotide for the treatment of intentional insulin aspart overdose in a non-diabetic patient.
Dewaal CM; McGillis E; Mink M; Lucyk S
CJEM; 2018 Jul; 20(4):643-647. PubMed ID: 29202888
[TBL] [Abstract][Full Text] [Related]
8. Prolonged hypoglycaemia after insulin lispro overdose.
Brvar M; Mozina M; Bunc M
Eur J Emerg Med; 2005 Oct; 12(5):234-5. PubMed ID: 16175061
[TBL] [Abstract][Full Text] [Related]
9. Intentional Large Insulin Overdose Captured on a Continuous Glucose Monitor: A Novel Case Report.
El-Laboudi AH; Misra S; Martineau M; Deol P; Sanders A; Oliver N
J Diabetes Sci Technol; 2015 Jul; 9(4):929-31. PubMed ID: 25852072
[No Abstract] [Full Text] [Related]
10. A Case Involving Massive Insulin Overdose: Direct and Indirect Conditions Requiring Extended Management of Serum Potassium.
Miyakuni Y; Nakajima M; Kaszynski RH; Tarui T; Goto H; Yamaguchi Y
Am J Case Rep; 2020 Mar; 21():e920078. PubMed ID: 32179729
[TBL] [Abstract][Full Text] [Related]
11. Intravenous glucagon in a deliberate insulin overdose in an adolescent with type 1 diabetes mellitus.
White M; Zacharin MR; Werther GA; Cameron FJ
Pediatr Diabetes; 2016 Feb; 17(1):66-9. PubMed ID: 25229989
[TBL] [Abstract][Full Text] [Related]
12. Insulin overdose in eight patients: insulin pharmacokinetics and review of the literature.
Arem R; Zoghbi W
Medicine (Baltimore); 1985 Sep; 64(5):323-32. PubMed ID: 3897766
[TBL] [Abstract][Full Text] [Related]
13. Life-threatening hypoglycemia associated with intentional insulin ingestion.
Svingos RS; Fernandez EM; Reeder DN; Parker JJ
Pharmacotherapy; 2013 Mar; 33(3):e28-33. PubMed ID: 23456735
[TBL] [Abstract][Full Text] [Related]
14. Attempted suicide using insulin by a non diabetic: a case study demonstrating the acute and chronic consequences of profound hypoglycemia.
Cooper AJ
Can J Psychiatry; 1994 Mar; 39(2):103-7. PubMed ID: 8149313
[TBL] [Abstract][Full Text] [Related]
15. Lantus insulin overdose: a case report.
Lu M; Inboriboon PC
J Emerg Med; 2011 Oct; 41(4):374-7. PubMed ID: 20493654
[TBL] [Abstract][Full Text] [Related]
16. Intentional overdose with insulin glargine and insulin aspart.
Tofade TS; Liles EA
Pharmacotherapy; 2004 Oct; 24(10):1412-8. PubMed ID: 15628838
[TBL] [Abstract][Full Text] [Related]
17. Intentional overdose with insulin glargine.
Ashawesh K; Padinjakara RN; Murthy NP; Nizar H; Anwar A
Am J Health Syst Pharm; 2009 Mar; 66(6):534. PubMed ID: 19265181
[No Abstract] [Full Text] [Related]
18. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P
Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996
[TBL] [Abstract][Full Text] [Related]
19. Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia.
Lorenzi M; Bohannon N; Tsalikian E; Karam JH
West J Med; 1984 Oct; 141(4):467-71. PubMed ID: 6390972
[TBL] [Abstract][Full Text] [Related]
20. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
